Novo Holdings A/S as of Sept. 30, 2025
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 27 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 22.0 | $341M | 1.0M | 328.17 | |
| Brookfield Corp Cl A Ltd Vt Sh (BN) | 10.3 | $160M | 2.3M | 68.58 | |
| Asml Holding N V N Y Registry Shs (ASML) | 9.1 | $141M | 146k | 968.09 | |
| Mirum Pharmaceuticals (MIRM) | 6.0 | $93M | 1.3M | 73.31 | |
| Edgewise Therapeutics (EWTX) | 5.6 | $87M | 5.4M | 16.22 | |
| salesforce (CRM) | 5.0 | $78M | 330k | 237.00 | |
| Merus N V (MRUS) | 4.6 | $71M | 750k | 94.15 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.4 | $68M | 1.6M | 41.65 | |
| Miragen Therapeutics (VRDN) | 3.3 | $51M | 2.4M | 21.58 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 3.0 | $46M | 257k | 178.73 | |
| Zenas Biopharma (ZBIO) | 2.9 | $44M | 2.0M | 22.20 | |
| Pharvaris N V (PHVS) | 2.8 | $44M | 1.8M | 24.95 | |
| Recursion Pharmaceuticals In Cl A (RXRX) | 2.5 | $39M | 7.9M | 4.88 | |
| Arrivent Biopharma (AVBP) | 2.3 | $36M | 1.9M | 18.45 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $36M | 660k | 54.16 | |
| Vaxcyte (PCVX) | 2.1 | $33M | 916k | 36.02 | |
| Celldex Therapeutics Com New (CLDX) | 2.0 | $31M | 1.2M | 25.87 | |
| Enliven Therapeutics (ELVN) | 1.9 | $29M | 1.4M | 20.47 | |
| Insmed Com Par $.01 (INSM) | 1.9 | $29M | 200k | 144.01 | |
| Valneva Se Sponsored Ads (VALN) | 1.8 | $29M | 2.3M | 12.20 | |
| Bridgebio Oncology Therapeut Com New | 1.5 | $23M | 2.0M | 11.58 | |
| Apogee Therapeutics (APGE) | 1.3 | $20M | 500k | 39.73 | |
| 4d Molecular Therapeutics In (FDMT) | 1.1 | $17M | 2.0M | 8.69 | |
| Lanzatech Global Com New | 0.2 | $3.9M | 158k | 24.51 | |
| Marqeta Class A Com (MQ) | 0.2 | $2.3M | 442k | 5.28 | |
| Io Biotech (IOBT) | 0.1 | $912k | 2.5M | 0.36 | |
| Galecto Com New (GLTO) | 0.0 | $322k | 87k | 3.72 |
